Accelerating drug development and approval.

Abstract

Regulatory agencies are the gateway between the pharma/biotech industry and patients and can serve as stimulators of new drug development. This article highlights several means of doing so implemented thus far, many with already impressive histories, such as orphan drug legislation, and others of a more experimental nature, such as the FDA's priority review… (More)
DOI: 10.1358/dnp.2010.23.1.1441464

Topics

Cite this paper

@article{Cole2010AcceleratingDD, title={Accelerating drug development and approval.}, author={Patrick Cole}, journal={Drug news & perspectives}, year={2010}, volume={23 1}, pages={37-47} }